Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
81 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
Global autoimmune disease diagnostics market is expected to reach USD 14.17 billion by 2020. Growing prevalence of autoimmune diseases coupled with the presence of favorable government initiatives such as the Affordable Care Act is expected to positively reinforce the autoimmune disease diagnostics market. Slow turnaround duration and presence of fewer diagnostic tests catering to nearly 80 disease types and the consequent rise in lab automation rates are expected to drive market growth during the forecast period. Automation of laboratories is expected enable clinicians with the ability to conduct several diagnostic tests simultaneously and generate accurate and rapid results. Technological advances such as the development of novel biomarkers and portable diagnostic point of care equipment are further expected to boost procedure volumes.
Systemic autoimmune disease diagnostics is the most lucrative segment of this market. Presence of high unmet patient needs in disease segments such as rheumatoid arthritis and systemic lupus E. coupled with the introduction of new products for example Avise SLE marker for lupus diagnosis are some factors expected to drive segment growth over the next six years. In addition, implementation of initiatives aimed at developing effective diagnostic and therapeutic solutions for systemic diseases with high prevalence for instance rheumatoid arthritis is further expected to drive segment growth.
Further key findings from the study suggest:
Rheumatoid arthritis emerged as the fastest growing product segment. Its market is expected to grow at a CAGR of over 4.0% from 2014 to 2020. High prevalence of rheumatoid arthritis and the involvement of expensive assessment tests are few factors attributing to its rapid growth.
Localized autoimmune disease diagnostics was the leading product segment of this market in 2013. Extensive presence of commercialized diagnostic products and growing prevalence of gastrointestinal autoimmune disorders are some factors accounting for its large share.
North America was the largest regional market in 2013, accounting for a share of over 40.0%. Its large share is attributed by the introduction of the Affordable Care Act, presence of favorable initiatives undertaken by the AARDA and high disease prevalence levels in the region.
Asia Pacific is expected to witness promising growth over the next six years. Constantly improving healthcare infrastructure and patient awareness levels in the emerging markets of India and China have now opened up new avenues for the manufacturers to capitalize on.
Some key players of the autoimmune disease diagnostics market include Abbott Laboratories, Quest Diagnostics, Siemens Healthcare, Beckman Coulter Inc. and SQI Diagnostics.
Introduction of technologically innovative products such as Celiac panel tests enabling faster IgG & IgA antibodies detection is one of the major sustainability strategies adopted by the market players
For the purpose of this study, Grand View Research has segmented the global autoimmune disease diagnostics market on the basis of product and region:
Global Autoimmune Disease Diagnostics Product Outlook (Revenue, USD Billion, 2012 - 2020)
Systemic Autoimmune Disease Diagnostics
Rheumatoid Arthritis Diagnostics
Ankylosing Spondylitis Diagnostics
Systemic Lupus Erythematosus (SLE)
Localized Autoimmune Disease Diagnostics
Autoimmune Disease Diagnostics Regional Outlook (Revenue, USD Billion, 2012 - 2020)
North America
U.S.
Canada
Europe
Germany
UK
Asia Pacific
China
Japan
RoW
Brazil
Table of Contents
Chapter 1 Executive Summary Chapter 2 Autoimmune Disease Diagnostics Industry Outlook 2.1 Market Segmentation 2.2 Market Size and Growth Prospects 2.3 Autoimmune disease diagnostics - Market dynamics 2.3.1 Market Driver Analysis 2.3.1.2 Presence of research funding programs 2.3.1.3 Presence of favorable government initiatives 2.3.1.4 Growing patient awareness levels 2.3.1.5 Technological innovation in the form of lab automation 2.3.2 Market Restraint Analysis 2.3.2.1 Slow diagnostic result turnaround times and lack of skilled healthcare practitioners 2.4 Key Opportunities Prioritized 2.5 Industry Analysis - Porter's 2.6 Autoimmune Disease Diagnostics - PESTEL Analysis Chapter 3 Autoimmune Disease Diagnostics Product Outlook 3.1 Autoimmune disease diagnostics market share by product, 2013 & 2020 3.2 Systemic Autoimmune disease diagnostics 3.2.1 Systemic autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 3.2.2 Rheumatoid arthritis diagnostics market, 2012 - 2020 (USD Million) 3.2.3 Ankylosing spondylitis diagnostics market, 2012 - 2020 (USD Million) 3.2.4 Systemic lupus erythematosus (SLE) diagnostics market, 2012 - 2020 (USD Million) 3.3 Localized disease diagnostics 3.3.1 Localized disease diagnostics market, 2012 - 2020 (USD Million) Chapter 4 Autoimmune Disease Diagnostics Regional Outlook 4.1 Autoimmune disease diagnostics market share by region, 2013 & 2020 4.2 North America 4.2.1 North America autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 4.2.2 U.S. autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 4.2.3 Canada autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 4.3 Europe 4.3.1 Europe autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.3.2 Germany autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 4.3.3 UK autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.4 Asia Pacific 4.4.1 Asia Pacific autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.4.2 China autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.4.3 Japan autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.5 RoW 4.5.1 RoW autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.5.2 Brazil autoimmune disease diagnostics market, 2012-2020 (USD Million) Chapter 5 Competitive Landscape 5.1 Abbott Laboratories 5.1.1 Company Overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.2 Siemens Healthcare 5.2.1 Company Overview 5.2.2 Financial Performance 5.2.3 Product Benchmarking 5.2.4 Strategic Initiatives 5.3 Roche Diagnostics 5.3.1 Company Overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.4 Beckman Coulter Inc. 5.4.1 Company Overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.5 SQI Diagnostics Inc. 5.5.1 Company Overview 5.5.2 Financial Performance 5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 EUROIMMUN 5.6.1 Company Overview 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 AESKU DIAGNOSTICS 5.7.1 Company Overview 5.7.2 Financial Performance 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives 5.8 INOVA Diagnostics Inc. 5.8.1 Company Overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking 5.8.4 Strategic Initiatives 5.9 Crescendo Bioscience Inc 5.9.1 Company Overview 5.9.2 Financial Performance 5.9.3 Product Benchmarking 5.9.4 Strategic Initiatives 5.10 bioMerieux SA. 5.10.1 Company Overview 5.10.2 Financial Performance 5.10.3 Product Benchmarking 5.10.4 Strategic Initiatives 5.11 Bio-Rad Laboratories Inc. 5.11.1 Company Overview 5.11.2 Financial Performance 5.11.3 Product Benchmarking 5.11.4 Strategic Initiatives 5.12 Hemagen Diagnostics Inc. 5.12.1 Company Overview 5.12.2 Financial Performance 5.12.3 Product Benchmarking 5.13 Quest Diagnostics. 5.13.1 Company Overview 5.13.2 Financial Performance 5.13.3 Product Benchmarking 5.13.4 Strategic Initiatives Chapter 6 Methodology and Scope 6.1 Research Methodology 6.2 Research Scope & Assumptions 6.3 List of Data Sources List of Tables
1. Autoimmune Disease Diagnostics - Industry summary & Critical Success Factors (CSFs) 2. Global autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 3. Global autoimmune disease diagnostics market, by region, 2012 - 2020 (USD Million) 4. Autoimmune Disease Diagnostics - Key market driver analysis 5. List of NIH funding programs, 2013 6. Autoimmune Disease Diagnostics - Key market restraint analysis 7. Potential biomarkers and their potential applications in treating systemic lupus E. 8. North America autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 9. North America systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 10. U.S. autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 11. U.S. systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 12. Canada autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 13. Canada systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 14. Europe autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 15. Europe systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 16. Germany autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 17. Germany systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 18. UK autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 19. U.K systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 20. Asia Pacific autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 21. Asia Pacific systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 22. China autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 23. China systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 24. Japan autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 25. Japan systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 26. RoW autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 27. RoW systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 28. Brazil autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) 29. Brazil systemic autoimmune disease diagnostics market, by product, 2012 - 2020 (USD Million) List of Figures 1. Autoimmune disease diagnostics: Market segmentation 2. Global autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 3. Autoimmune disease diagnostics market dynamics 4. Disease incidence rates per 100,000, by type, 2013 5. Total autoimmune related NIH funding, 2011 - 2014 (USD Million) 6. Key Opportunities Prioritized 7. Autoimmune disease diagnostics market - Porter's analysis 8. Autoimmune disease diagnostics market - PESTEL analysis 9. Autoimmune disease diagnostics market share by product, 2013 & 2020 10. Implementation of the AMP RA/SLE program, by research phase 11. Global systemic autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 12. Global rheumatoid arthritis diagnostics market, 2012 - 2020 (USD Million) 13. Global Ankylosing spondylitis market, 2012 - 2020 (USD Million) 14. Global systemic lupus erythematosus (SLE) diagnostics market, 2012 - 2020 (USD Million) 15. Global localized disease diagnostics market, 2012 - 2020 (USD Million) 16. Autoimmune disease diagnostics market share by region, 2013 & 2020 17. North America autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 18. U.S. autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 19. Canada autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 20. Europe autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 21. Germany autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 22. UK autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 23. Asia Pacific autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 24. China autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 25. Japan autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 26. RoW autoimmune disease diagnostics market, 2012 - 2020 (USD Million 27. Brazil autoimmune disease diagnostics market, 2012 - 2020 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
